In clinical setting of platinum-based chemotherapy for NSCLC, patients with undetectable SLC31A1 in tumors have reduced platinum concentration, decreased tumor response and shorter survival 4, 6, while ABCG2 expression in biopsy specimen predicts shorter survival 7, 8. The gene discussed is ABCG2; the disease is non-small cell lung carcinoma.